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Introduction 
An increase in the incidence of endometrial cancer requires not only early 
detection of this disease, but also appropriate treatment, taking into account 
clinical, morphological, molecular-genetic prognostic factors and the frequency 
of recurrences (fig.1,2). 
 
Purpose 
The aim of this study was to study the morphological factors of the prognosis and 
the characteristics of endometrial cancer recurrence in stage I-II, with the 
introduction of a classification based on the molecular characteristics of tumors.  
  
Material and methods 
The study represents a complex, 
prospective analysis of clinical-
morphological data and recurrence 
rates in 200 patients with stage I-II 
who were treated at the Department 
of Gynecological Oncology of the 
Institute of Oncology of the Republic 
of Moldova for 2015-2018, based on 
ESGO risk criteria (fig.3). 
 
Results 
Free interval before recurrence was 24 months. In 11 patients, recurrence 
developed up to 24 months and in 9 to 60 months. An indicator of the 
aggressiveness of the tumor process is cell proliferation, which can be 
assessed using the percentage of Ki-67 positive nuclei(fig.5). A high 
percentage of Ki-67 is associated with an unfavorable prognosis of the EC. 
When analyzing the expression index Ki-67, it was found that in the low-risk 
group of patients with EC, the Ki-67 index was 14%, from the group with 
intermediate risk, the expression level was 25.5%, from the high risk 
group(fig.4). 
Conclusions 
In the first three years of observation, recurrences of the underlying disease 
were observed in the general group of patients examined with EC in stage I-
II. Of the 200 patients with stage I-II, recurrences and metastases were 
detected in 20 (40%) patients. Clarification of the risk group during the 
initial examination and immediately after the surgical treatment of patients 
with endometrial cancer using clinical, morphological and 
immunohistochemical methods and our results make it reasonable to 
monitor EC at early stages even in the low-risk group and to search for new 
molecular genetic prognostic factors. 
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